n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine has been researched along with novobiocin in 1 studies
Studies (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Trials (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Recent Studies (post-2010) (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Studies (novobiocin) | Trials (novobiocin) | Recent Studies (post-2010) (novobiocin) |
---|---|---|---|---|---|
25 | 0 | 12 | 2,271 | 15 | 290 |
Protein | Taxonomy | n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine (IC50) | novobiocin (IC50) |
---|---|---|---|
DNA gyrase subunit B | Mycolicibacterium smegmatis MC2 155 | 0.046 | |
DNA gyrase subunit B | Staphylococcus aureus | 0.0474 | |
DNA gyrase subunit B | Streptococcus pneumoniae TIGR4 | 0.037 | |
DNA gyrase subunit A | Escherichia coli K-12 | 0.1441 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.1537 | |
DNA topoisomerase 4 subunit B | Staphylococcus aureus | 7.9 | |
DNA gyrase subunit B | Mycolicibacterium smegmatis | 0.161 | |
DNA gyrase subunit A | Staphylococcus aureus | 0.0383 | |
DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 0.0446 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 0.1315 | |
DNA topoisomerase | Streptococcus pneumoniae | 2.03 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
1 other study(ies) available for n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and novobiocin
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |